O100 - A peptide from the known HLA class I restricted melanoma-specific tumor antigen GP100 is presented by HLA-DR in the melanoma cell line FM3

Identification of a novel peptide derive

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

✍ Alexander B. H. Barker; Marco W. J. Schreurs; Gaalda Tafazzul; Annemiek J. De Bo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 633 KB

## Abstract Cytotoxic T lymphocytes (CTL) reactive with human melanoma tumor cells occasionally display cross‐reactivity with normal melanocytes. Previously, we identified the melanocyte lineage‐specific antigen gp100 that is expressed by both melanoma cells and normal melanocytes, as a target anti